Found: 16
Select item for more details and to access through your institution.
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19.
- Published in:
- Genes, Chromosomes & Cancer, 2009, v. 48, n. 10, p. 854, doi. 10.1002/gcc.20688
- By:
- Publication type:
- Article
Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
- Published in:
- Molecular Medicine, 2019, v. 25, n. 1, p. 1, doi. 10.1186/s10020-019-0116-z
- By:
- Publication type:
- Article
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05373-4
- By:
- Publication type:
- Article
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac130
- By:
- Publication type:
- Article
PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2018.00670
- By:
- Publication type:
- Article
Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous Process.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cells.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0208341
- By:
- Publication type:
- Article
RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1261, doi. 10.1093/neuonc/noac051
- By:
- Publication type:
- Article
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 384, doi. 10.1093/neuonc/noab162
- By:
- Publication type:
- Article
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2042, doi. 10.1093/neuonc/noab133
- By:
- Publication type:
- Article
Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX lines.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2066, doi. 10.1093/neuonc/noab137
- By:
- Publication type:
- Article
Molecular profiling of long-term IDH-wildtype glioblastoma survivors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 11, p. 1458, doi. 10.1093/neuonc/noz129
- By:
- Publication type:
- Article
Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 6, p. 735, doi. 10.1093/neuonc/not010
- By:
- Publication type:
- Article
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 7, p. 870, doi. 10.1093/neuonc/nos114
- By:
- Publication type:
- Article
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.
- Published in:
- Neuro-Oncology, 2009, v. 11, n. 3, p. 281, doi. 10.1215/15228517-2008-090
- By:
- Publication type:
- Article